Skip to main content
Caplight Logo









CV6 Therapeutics

CV6 Therapeutics

Private
BelfastHealthcare & Life Scienceshttps://cv6t.com/

Last Round

Grant

Nov 2, 2022

Total Funding Raised

$3.45M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CV6 Therapeutics is a biotechnology company that develops small-molecule combination therapies for the treatment of cancer and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaloncologysmall moleculedrug discoveryDNA repaircancer therapeuticsclinical-stagechemotherapy sensitizationsolid tumorsbiotechdrug developmentclinical trialscancer researchtherapeutic pipelinepharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CV6 Therapeutics Comparables

Compare CV6 Therapeutics with similar companies based on industry and business-model similarity.

CV6 Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Breakpoint Therapeutics
85%
FoRx Therapeutics
83%
Hemispherian AS
83%

CV6 Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 2, 2022
VC RoundNov 2, 2022

Key People

Founding team and executive leadership

Robert D. Ladner, Ph.D.

Chief Executive Officer and Founder

Founding Team

Karl Mulligan

Chief Operating Officer

Executive Team

CV6 Therapeutics Investors

Notable investors and investment history

CV6 Therapeutics investors
InvestorRounds
QUBISVC Round
Invest Northern IrelandGrant, VC Round
Clarendon Fund ManagersVC Round
Techstart VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 35% to 2.8K.

  • Apr 16, 2026

    Monthly visitors increased 32% MoM, reaching 2.3K.

CV6 Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CV6 Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CV6 Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelfast
Employee Range10
Year Founded2012
Last FundingNov 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?